Danielle is a Senior Associate with the Biotechnology team. Danielle focuses on the preparation and prosecution of patent applications, patentability, infringement, clearance, and validity opinions, and due diligence work, with a specialty in biopharmaceuticals (including antibodies and antisense molecules), diagnostics and agriculture (including transgenic plants). Danielle works with a number of local and overseas biotech companies, including small to medium entities, big pharma and generics companies as well as academic institutions to protect their intellectual property and help them avoid infringing competitor's intellectual property rights. Danielle has represented clients in oppositions to grant of both Australian and New Zealand patents and has prepared patent attorney reports required in prospectuses for initial public offerings.
Danielle has extensive industry experience, having worked as a postdoctoral scientist at BIO21 where she was involved in the expression and purification of proteins involved in Influenza-specific viral immunity.
Danielle graduated from the University of Melbourne with a BSc (Hons) majoring in Biochemistry and Immunology. She was awarded the Australian Society for Microbiology 3rd Year Prize, the Exhibition Prize for Microbiology and the Peter J Doos Award.
Danielle also completed a PhD in Immunology at the University of Melbourne. Danielle’s PhD examined the impact of natural variation in genes that control immunity; her work showed how very slight differences in certain immune response genes result in dramatic changes in the response to viral infection. Her studies help explain how genetic variation alters immunity to infections and controls transplant rejection.
Danielle has authored and co-authored several research publications.
Danielle is a registered Australian Patent Attorney.